Latest filing published 17 Nov 2021 for bluebird bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of William R. Sellers across 2 companies, led by bluebird bio, Inc. and 2seventy bio, Inc. In total, 3 filings cover trades dated from 15 June 2021 to 11 November 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 November 2021 came the latest disclosure, a transaction in bluebird bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations